Bexitrol F (25 mcg+125 mcg)/puff (Inhaler)
120 metered doses: ৳ 595.00
Medicine Details
Category | Details |
---|---|
Generic | Salmeterol fluticasone propionate |
Company | Beximco pharmaceuticals ltd |
Also available as |
Indications
- Regular treatment of asthma
- Combination product for inadequate control of inhaled corticosteroids
- Effective for patients already controlled on inhaled corticosteroid and long-acting β2-agonist
Pharmacology
- Salmeterol Xinafoate as a selective, long-acting beta-2 agonist
- Fluticasone Propionate acts through glucocorticoid activity
- Salmeterol protects against symptoms, Fluticasone Propionate improves lung function and prevents exacerbations
Dosage
- Adult and adolescent dosage for inhaler
- Children dosage for inhaler
- Dosage for asthma inhalation capsule for adults and adolescents
- Dosage for asthma inhalation capsule for pediatric patients
- Dosage for COPD inhalation capsule
- Dosage for Maxhaler in adults, adolescents, and children
- Dosage for COPD using Maxhaler
Administration
- Instructions for using Inhaler correctly
- Guidelines for effective Inhaler usage
- Instructions for cleaning the Inhaler
Interaction
- Avoidance of non-selective and selective β-blockers
- Potential interactions with known strong CYP3A4 inhibitors
Contraindications
- Contraindicated in patients with hypersensitivity to specific components
- Contraindicated in primary treatment of status asthmaticus or acute episodes of asthma
Side Effects
- Adverse reactions associated with Salmeterol and Fluticasone Propionate
- Manifestation of side effects for each compound separately
Pregnancy & Lactation
- Consideration of use in pregnancy and lactation
- Insufficient human experience for use in pregnancy and lactation
Precautions & Warnings
- Use not recommended during asthma exacerbation or unstable asthma
- Warning for serious asthma-related adverse events
- Potential occurrence of paradoxical bronchospasm
- Increased risk of pneumonia in COPD patients
- Potential systemic effects of corticosteroids
Use in Special Populations
- Potential impact of corticosteroids on growth velocity in pediatric patients
Overdose Effects
- No reported human overdose data for Bexitrol F inhaler
- Signs and symptoms of Salmeterol and Fluticasone Propionate overdose
Therapeutic Class
- Belongs to the therapeutic classes of long-acting selective β-adrenoceptor stimulants and Respiratory corticosteroids
Storage Conditions
- Storage guidelines for pressurised canister
Related Brands
- Aroflo (25 mcg+125 mcg)/puff (Inhaler) - aristopharma-ltd
- Aroflo (25 mcg+250 mcg)/puff (Inhaler) - aristopharma-ltd
- Arotide (25 mcg+125 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
- Arotide (25 mcg+250 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
- Bexitrol F (25 mcg+50 mcg)/puff (Inhaler) - beximco-pharmaceuticals-ltd